
Amy Jo Sterling
Examiner (ID: 4242, Phone: (571)272-6823 , Office: P/3631 )
| Most Active Art Unit | 3631 |
| Art Unit(s) | 3632, 3631 |
| Total Applications | 2801 |
| Issued Applications | 2050 |
| Pending Applications | 118 |
| Abandoned Applications | 672 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1230428
[patent_doc_number] => 06692748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-17
[patent_title] => 'Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2'
[patent_app_type] => B2
[patent_app_number] => 10/012605
[patent_app_country] => US
[patent_app_date] => 2001-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42430
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/692/06692748.pdf
[firstpage_image] =>[orig_patent_app_number] => 10012605
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/012605 | Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2 | Dec 6, 2001 | Issued |
Array
(
[id] => 6750942
[patent_doc_number] => 20030045463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/990437
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 331
[patent_figures_cnt] => 331
[patent_no_of_words] => 290704
[patent_no_of_claims] => 118
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045463.pdf
[firstpage_image] =>[orig_patent_app_number] => 09990437
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/990437 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Nov 15, 2001 | Abandoned |
Array
(
[id] => 928311
[patent_doc_number] => 07314619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-01
[patent_title] => 'Inducing apoptosis using anti-Apo-2 antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/052798
[patent_app_country] => US
[patent_app_date] => 2001-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 34
[patent_no_of_words] => 31851
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/314/07314619.pdf
[firstpage_image] =>[orig_patent_app_number] => 10052798
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/052798 | Inducing apoptosis using anti-Apo-2 antibodies | Nov 1, 2001 | Issued |
Array
(
[id] => 993813
[patent_doc_number] => 06916913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-12
[patent_title] => 'Dorsalin-1 polypeptide and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/002278
[patent_app_country] => US
[patent_app_date] => 2001-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 47
[patent_no_of_words] => 14765
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/916/06916913.pdf
[firstpage_image] =>[orig_patent_app_number] => 10002278
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/002278 | Dorsalin-1 polypeptide and uses thereof | Nov 1, 2001 | Issued |
Array
(
[id] => 724005
[patent_doc_number] => 07045318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-16
[patent_title] => 'Recombinant fusion proteins to growth hormone and serum albumin'
[patent_app_type] => utility
[patent_app_number] => 09/984010
[patent_app_country] => US
[patent_app_date] => 2001-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 12
[patent_no_of_words] => 6863
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/045/07045318.pdf
[firstpage_image] =>[orig_patent_app_number] => 09984010
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/984010 | Recombinant fusion proteins to growth hormone and serum albumin | Oct 25, 2001 | Issued |
Array
(
[id] => 6560499
[patent_doc_number] => 20020164701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Human gene marker for metabolic disease'
[patent_app_type] => new
[patent_app_number] => 10/001631
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29906
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164701.pdf
[firstpage_image] =>[orig_patent_app_number] => 10001631
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/001631 | Human gene marker for metabolic disease | Oct 24, 2001 | Abandoned |
Array
(
[id] => 7673381
[patent_doc_number] => 20040180398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Mammalian secretory protein Zsig43'
[patent_app_type] => new
[patent_app_number] => 10/033388
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29691
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180398.pdf
[firstpage_image] =>[orig_patent_app_number] => 10033388
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/033388 | Mammalian secretory protein Zsig43 | Oct 23, 2001 | Abandoned |
Array
(
[id] => 6874447
[patent_doc_number] => 20030194744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/017086
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 192313
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20030194744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10017086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/017086 | PRO274 nucleic acids | Oct 23, 2001 | Issued |
Array
(
[id] => 7678992
[patent_doc_number] => 20030195344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/999829
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 237
[patent_figures_cnt] => 237
[patent_no_of_words] => 192762
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20030195344.pdf
[firstpage_image] =>[orig_patent_app_number] => 09999829
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/999829 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Oct 23, 2001 | Abandoned |
Array
(
[id] => 6526963
[patent_doc_number] => 20020192706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/999832
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 192469
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192706.pdf
[firstpage_image] =>[orig_patent_app_number] => 09999832
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/999832 | PRO273 polypeptides | Oct 23, 2001 | Issued |
Array
(
[id] => 6721528
[patent_doc_number] => 20030055218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Human receptor proteins; related reagents and methods'
[patent_app_type] => new
[patent_app_number] => 10/011548
[patent_app_country] => US
[patent_app_date] => 2001-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35226
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055218.pdf
[firstpage_image] =>[orig_patent_app_number] => 10011548
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/011548 | Human receptor proteins; related reagents and methods | Oct 21, 2001 | Abandoned |
| 09/890053 | Pharmaceutical composition of hydrophobically modified hedgehog protein and their use | Oct 18, 2001 | Abandoned |
Array
(
[id] => 1247516
[patent_doc_number] => 06673343
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-06
[patent_title] => 'SAL-S1 receptor protein tyrosine kinase agonist antibodies'
[patent_app_type] => B2
[patent_app_number] => 09/982610
[patent_app_country] => US
[patent_app_date] => 2001-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 61
[patent_no_of_words] => 17061
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673343.pdf
[firstpage_image] =>[orig_patent_app_number] => 09982610
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/982610 | SAL-S1 receptor protein tyrosine kinase agonist antibodies | Oct 16, 2001 | Issued |
Array
(
[id] => 5739242
[patent_doc_number] => 20060009633
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2006-01-12
[patent_title] => 'Complementary DNAs encoding proteins with signal peptides'
[patent_app_type] => utility
[patent_app_number] => 09/978360
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 104854
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0009/20060009633.pdf
[firstpage_image] =>[orig_patent_app_number] => 09978360
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/978360 | Complementary DNAs encoding proteins with signal peptides | Oct 14, 2001 | Abandoned |
Array
(
[id] => 5739242
[patent_doc_number] => 20060009633
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2006-01-12
[patent_title] => 'Complementary DNAs encoding proteins with signal peptides'
[patent_app_type] => utility
[patent_app_number] => 09/978360
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 104854
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0009/20060009633.pdf
[firstpage_image] =>[orig_patent_app_number] => 09978360
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/978360 | Complementary DNAs encoding proteins with signal peptides | Oct 14, 2001 | Abandoned |
Array
(
[id] => 938496
[patent_doc_number] => 06972325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-06
[patent_title] => 'PRO273 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 09/978189
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 237
[patent_figures_cnt] => 237
[patent_no_of_words] => 190011
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/972/06972325.pdf
[firstpage_image] =>[orig_patent_app_number] => 09978189
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/978189 | PRO273 polypeptides | Oct 14, 2001 | Issued |
Array
(
[id] => 1173226
[patent_doc_number] => 06746674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-08
[patent_title] => 'Cytostatin II'
[patent_app_type] => B2
[patent_app_number] => 09/971187
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18295
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/746/06746674.pdf
[firstpage_image] =>[orig_patent_app_number] => 09971187
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/971187 | Cytostatin II | Oct 4, 2001 | Issued |
Array
(
[id] => 515875
[patent_doc_number] => 07189400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'Methods of treatment with antagonists of MU-1'
[patent_app_type] => utility
[patent_app_number] => 09/972218
[patent_app_country] => US
[patent_app_date] => 2001-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13106
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189400.pdf
[firstpage_image] =>[orig_patent_app_number] => 09972218
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/972218 | Methods of treatment with antagonists of MU-1 | Oct 3, 2001 | Issued |
Array
(
[id] => 968675
[patent_doc_number] => 06939950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-06
[patent_title] => 'Bovine tumor necrosis factor receptor-1 and methods of use'
[patent_app_type] => utility
[patent_app_number] => 09/970532
[patent_app_country] => US
[patent_app_date] => 2001-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6473
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/939/06939950.pdf
[firstpage_image] =>[orig_patent_app_number] => 09970532
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/970532 | Bovine tumor necrosis factor receptor-1 and methods of use | Oct 2, 2001 | Issued |
Array
(
[id] => 6813612
[patent_doc_number] => 20030073162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Signal peptide-containing proteins'
[patent_app_type] => new
[patent_app_number] => 09/968433
[patent_app_country] => US
[patent_app_date] => 2001-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22018
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073162.pdf
[firstpage_image] =>[orig_patent_app_number] => 09968433
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/968433 | SP16 protein | Sep 30, 2001 | Issued |